Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
2017 · Nature Communications · 173 citations
https://doi.org/10.1038/s41467-017-01385-8
Z
Zhenguo Cheng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
1.3K
Citations
20
h-index
32
i10-index
Zhenguo Cheng is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Virus-based gene therapy research & Cancer Research and Treatments & CAR-T cell therapy research. The author has an h-index of 20, co-authored 48 publications.
ORCID: 0000-0001-6375-3438Papers by this author
worksGRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC
2017 · Tumor Biology · 45 citations
https://doi.org/10.1177/1010428317704364
The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors
2024 · Cancer Letters · 44 citations
https://doi.org/10.1016/j.canlet.2024.216871
A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells
2017 · Molecular Therapy — Nucleic Acids · 35 citations
https://doi.org/10.1016/j.omtn.2017.07.005
A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer
2021 · Journal for ImmunoTherapy of Cancer · 34 citations
https://doi.org/10.1136/jitc-2020-001624
Micropeptide AF127577.4-ORF hidden in a lncRNA diminishes glioblastoma cell proliferation via the modulation of ERK2/METTL3 interaction
2024 · Scientific Reports · 14 citations
https://doi.org/10.1038/s41598-024-62710-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat